Enveric Biosciences, Inc.

ENVB Healthcare Biotechnology

In the quarter to June 2026, EPS grew 93.5% and free cash flow fell 29.3%, each against the same quarter a year earlier.

1.38 0.01 −0.72%
Market cap
$6.2M
P/E
0.0×
Fwd P/E
−3.6×
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
−4.74
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Total current assets
10.06 14.64 10.06 0.11 2.28 17.74 18.43 3.58 2.73 4.94
Total non-current assets
29.44 37.55 19.58 17.41 1.82 8.98 1.12 0.72 0.35 0.16
Total Assets
39.51 52.20 29.64 0.11 4.10 26.72 19.55 4.30 3.08 5.10
Total current liabilities
12.71 30.37 14.69 1.92 0.68 2.74 4.00 2.34 1.49 0.92
Total non-current liabilities
15.14 2.38 4.19 — — 1.68 0.89 — — —
Total liabilities
27.84 32.75 18.88 1.92 0.68 4.41 4.88 2.34 1.49 0.92
Common Equity (Total)
11.66 19.44 10.75 (1.81) 3.38 22.31 14.67 1.96 1.59 4.18
Shareholders Equity (Total)
11.66 19.45 10.76 (1.81) 3.42 22.31 14.67 1.96 1.59 4.18
Total Debt
18.63 7.18 5.21 0.74 — 0.18 0.06 — — —

Show all line items

In millions of $ except per-share values · columns are period end dates